Epstein Secrets

ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

y. Cifu is KNOWINGLY LYING Further: Recall: ANOTHER example of SEC corruption: the KCG 1Q2014 "astronomical" OTCM share volume metrics expunged by McKessy, Norberg, Pasquinelli, et al from the 1Q2014 10O: The KCG stand alone 1Q2014 10O: the basis of my March 2014 letter to McKessy with Berger Montague

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

ltiples of the revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve

revenue generated by stand alone KCG/Knight doing "similar or less" volume. The quarter I refer to: 1Q2014. EFTA00070049 My "March 2014 letter to McKessy". Where ANOTHER massive ibcrease in OTCM share volumes occurred. AND where an immediate investigation SHOULD have been triggered. It did not. In fac

My 2013 Knight/UBS TCR filed with Berger Montague in March 2013. Highlighted trading activity in Imaging Diagnostic Systems: IMDS. Despite glaring AML Red Flags involving entities subsequently cited by the SEC as Securities law violators, NITE and UBSS traded billions of shares. The SEC: Boston Director Leve